The biotech survey is an extremely rich survey, and I lobbied quite a lot of people to try to fund the 2007 survey of biotechnology. We could have had 10 years of looking very deeply into an industry in Canada. Unfortunately, I couldn't help to raise money for the survey. These types of studies allow us to examine how policy and various environments have an effect, because during the study we have done we passed through the crises of 2001 and 2007.
To give you an example, between 2007 and 2009, Quebec lost 20% more firms than it already had lost before, because firms die eventually. Quebec lost 10% of its 1999 cohort of firms by 2007, and then between 2007 and 2009, it lost a further 20%. It's as if Quebec had maintained these firms on artificial respiration. In Ontario or in B.C. the loss of these firms was much more gradual, so they didn't suffer as much in the 2008 financial crisis.
This is the kind of study we can do and it could be richer if we could merge it and look at patents and be able to merge patent with company data. I believe this is what Industry Canada is doing.